Gilbert Gottfried, iconic comedian, dies at 67 after long illness
Gottfried died at 2:35 p.m. ET on Tuesday from Recurrent Ventricular Tachycardia due to Myotonic Dystrophy type II. #gilbertgottfried (Source: Reuters: Health)
Source: Reuters: Health - April 12, 2022 Category: Consumer Health News Source Type: news
U.S. FDA Approves CARVYKTI ™ (ciltacabtagene autoleucel), Janssen’s First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
HORSHAM, Pa., February 28, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has approved CARVYKTI™ (ciltacabtagene autoleucel; cilta-cel) for the treatment of adults with relapsed or refractory multiple myeloma (RRMM) after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.1 The approval is based on data from the pivotal CARTITUDE-1 study, which included patients who had received a median of six prior treatment regimens (range, 3-18), and had previously rec...
Source: Johnson and Johnson - March 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Transcutaneous Magnetic Stimulation Promising Against VT Storm Transcutaneous Magnetic Stimulation Promising Against VT Storm
New data suggest transcutaneous magnetic stimulation of the left stellate ganglion is a promising and noninvasive strategy to reduce episodes of ventricular tachycardia storm.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - February 22, 2022 Category: Emergency Medicine Tags: Cardiology News Source Type: news
Is Ventricular Tachycardia Serious?
Title: Is Ventricular Tachycardia Serious?Category: Diseases and ConditionsCreated: 1/20/2022 12:00:00 AMLast Editorial Review: 1/20/2022 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 20, 2022 Category: Cardiology Source Type: news
Effect of Anesthesia Depth on RFCA of Ventricular Tachycardia Effect of Anesthesia Depth on RFCA of Ventricular Tachycardia
This study compared the effects of different anesthesia depths on the inducibility of ventricular tachycardia during radiofrequency catheter ablation and on postoperative outcomes.BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2022 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news
How one health system is using radiation to treat heart patients who ’ve run out of options
Ventricular tachycardia (VT) is a common, potentially life-threatening heart arrhythmia that occurs in the organ ’s lower chambers in patients with heart disease or heart failure, which can lead to sudden cardiac death. While there are a variety of treatments, not all of them work for people suffering from the disorder.
One of the most common treatments, a cardiac catheter ablation, can fail nearly half of the time in preventing further episodes of VT. Medication is another option, but sometimes… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 12, 2021 Category: Biotechnology Authors: Laura Newpoff Source Type: news
Apple study finds Watch can detect more types of irregular heartbeats
The most common arrhythmias detected were premature atrial contractions, premature ventricular contractions, atrial tachycardia and nonsustained ventricular tachycardia. (Source: mobihealthnews)
Source: mobihealthnews - September 29, 2021 Category: Information Technology Source Type: news
What Is the Best Treatment of Ventricular Tachycardia?
Title: What Is the Best Treatment of Ventricular Tachycardia?Category: Diseases and ConditionsCreated: 9/2/2021 12:00:00 AMLast Editorial Review: 9/2/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 2, 2021 Category: Cardiology Source Type: news
Cardiac Manifestations 6 Months After Resolution of COVID-19 Cardiac Manifestations 6 Months After Resolution of COVID-19
This case of a patient with exertional dyspnea and ventricular tachycardia months after COVID-19 recovery suggests possible long-term cardiac involvement after resolution of even a mild case of COVID.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Varian Receives FDA "Breakthrough Device Designation" for its Cardiac Radioablation (CRA) System for Treatment of Refractory Ventricular Tachycardia (VT)
Varian's CRA system has been designated a "breakthrough device" by the FDA because of its potential to offer a more effective treatment for select patients with refractory VT.
Technology being developed will be assessed in clinical studies as ... Devices, Cardiology, FDA Varian, Cardiac Radioablation, Ventricular Tachycardia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 26, 2021 Category: Pharmaceuticals Source Type: news
More about chloroquine and hydroxychloroquine, CEBM (updated 30th August 2020)
VERDICT
The hypothesis that the 4-aminoquinolines chloroquine and hydroxychloroquine may be beneficial in the treatment of COVID-19 is a weak one, based on poor mechanistic reasoning and inconsistent results of studies in vitro, in laboratory animals, and in humans.
It is likely that even if chloroquine and hydroxychloroquine are effective in COVID-19, the beneficial effects will be small.
The risks of adverse reactions to these drugs may be increased in patients who are acutely ill with severe COVID-19, in many of whom high doses are being used.
Macrolide antibacterial drugs, such as azithromycin, clarithromycin, ery...
Source: Current Awareness Service for Health (CASH) - September 2, 2020 Category: Consumer Health News Source Type: news
TCMS Linked to Lower Burden of Ventricular Tachycardia Storm TCMS Linked to Lower Burden of Ventricular Tachycardia Storm
A pilot study in which transcutaneous magnetic stimulation was used to treat refractory ventricular tachycardia storm shows a lower burden of sustained and unsustained ventricular tachycardia after 48 hours.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 9, 2020 Category: Intensive Care Tags: Cardiology News Source Type: news
More about chloroquine and hydroxychloroquine, CEBM
VERDICT:
The hypothesis that the 4-aminoquinolines chloroquine and hydroxychloroquine may be beneficial in the treatment of COVID-19 is a weak one, based on poor mechanistic reasoning and inconsistent results of studies in vitro, in laboratory animals, and in humans. It is likely that even if chloroquine and hydroxychloroquine are effective in COVID-19, the beneficial effects will be small.
The risks of adverse reactions to these drugs may be increased in patients who are acutely ill with severe COVID-19, in many of whom high doses are being used.
Macrolide antibacterial drugs, such as azithromycin, clarithromycin, ery...
Source: Current Awareness Service for Health (CASH) - June 1, 2020 Category: Consumer Health News Source Type: news
What Causes Tachycardia?
Discussion
Tachycardia is a rapid heart rate that is above normal for age and level of exertion. Tachycardia is common, particularly sinus tachycardia due to normally encountered circumstances such as pain, fever or exercise. It is usually a normal physiologic process but sustained tachycardia often indicates a potentially abnormal underlying cause.
Sinus tachycardia has a rapid heart rate with normal P waves and P-R intervals and variations from moment to moment and respiration. Generally it is not over 200 beats/minute. Vagal stimulation can slow the heart rate; this is a gradual slowing, not an abrupt slowing seen in ...
Source: PediatricEducation.org - March 23, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Heart condition can be cured with a quick blast of lung cancer therapy
Ventricular tachycardia is a major cause of sudden cardiac death, and kills more than 100,000 in the UK every year. Tests show the abnormal rhythm can be corrected with a pain-free blast of radiotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - February 15, 2020 Category: Consumer Health News Source Type: news
